[1]邓珊 翁保慧(审校).脑卒中可干预性危险因素的研究现状[J].内科,2015,(01):99-102.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.43]
 [J].Internal Medicine of China,2015,(01):99-102.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.43]
点击复制

脑卒中可干预性危险因素的研究现状()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2015年01期
页码:
99-102
栏目:
综述
出版日期:
2015-02-25

文章信息/Info

文章编号:
1673-7768(2015)01-0099-04
作者:
邓珊 翁保慧(审校)
广西医科大学第四附属医院神经内科,柳州市545005
关键词:
脑卒中可干预性危险因素高血压房颤综述
分类号:
R 743
DOI:
DOI:10.16121/j.cnki.cn45-1347/r.2015.01.43
文献标志码:
A
摘要:
许多卒中的危险因素是可以预防或可以控制的,通过有效的人为干预,即可降低卒中患病率,减轻患者致残程度,提高生活质量。本文就卒中可干预性危险因素如高血压、房颤、糖尿病等的研究现状及预防控制情况进行简要综述。

参考文献/References:

[1]Kannel WB,Wolf PA,Verter J,et al.Epidemiologic assessment of the role of blood pressure in stroke. The framinghamstudy[J].JAMA,1970,214:301-310. [2]Staessen JA,Jiguang W.Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack[J].Lancet,2001,358:1033-1041. [3]Kimmo Herttua,Adam G.Tabák,PekkaMartikainen,et al.Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults:population-based study[J].Eur Heart,2013,34(38,SI):2933-2939. [4]Levy S,MaarekM,CoumelP,et al.Characterization of different subsets of atrial fibrillation in general practice in France:the ALFA study[J].The College of French Cardiologists.Circulation,1999,99(23):3028-3035. [5]Krahn AD,Manfreda J,Tate RB,et al.The natural history of atrial fibrillation:incidence,risk factors,and prognosis in the Manitoba Follow-Up Study[J].Am J Med,1995,98(5):476-484. [6]Atrial Fibrilation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154(13):1449-1457. [7]Flegel KM,Shipley MJ,Rose G.Risk of stroke in non-rheumatic atrial fibrillation[J].Lancet,1987,1(8532):526-529. [8]胡大一,孙艺红,周自强,等.中国人非瓣膜性心房颤动脑卒中危险因素的病例对照研究[J].中华内科杂志,2003,42(3):16-20. [9]Wolf PA,AbbottRD,Kannel WB,et al.Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[J].Stroke,1991,22(8):983-988. [10]Mant J,Hobbs FD,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomised controlled trial[J].Lancet,2007,370(9586):493-503. [11]ACTIVE Writing Group of the ACTIVE Investigators1,Connolly S,Pogue J,et al.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W):a randomised controlled trial[J].Lancet,2006,367(9526):1903-1912. [12]Pérez-Gómez F,Alegría E,Berjón J,et al.Comparative effects of antiplatelet,anticoagulant,or combined therapy in patients with valvular and nonvalvular atrial fibrillation:a randomized multicenter study[J].J Am Coll Cardiol,2004,44(8):1557-1566. [13]Khoury JC,Kleindorfer D,Alwell K,et al.Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population[J].Stroke,2013,44(6):1500. [14]Banerjee C,Moon YP,Paik MC,et al.Duration of diabetes and risk of ischemic stroke:the Northern Manhattan Study[J].Stroke,2012,43(5):1212-1217. [15]Action to Control Cardiovascular Risk in Diabetes Study Group,Gerstein HC,Miller ME,et al.Effects of intensive glucose lowering in type 2 diabetes[J],2008,358(24):2545-2559. [16]ADVANCE Collaborative Group,Patel A,MacMahon S,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].NEngl J Med,2008,358(24):2560-2572. [17]Duckworth W,Abraira C,Moritz T,et al.Glucose control and vascular complications in veterans with type 2 diabetes[J].NEngl J Med,2009,360(2):129-139. [18]Amarenco P,Bogousslavsky J,Callahan A 3rd,et al.High-dose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355(6):549-559. [19]Xu T,Bu X,Li H,et al.Smoking,heart rate,and ischemic stroke:a population-based prospective cohort study among Inner Mongolians in China[J].Stroke,2013,44(9):2457-2461. [20]Xu L,Schooling CM,Chan WM,et al.Smoking and hemorrhagic stroke mortality in a prospective cohort study of older Chinese[J].Stroke,2013,177(11):S39. [21]Ikehara S,Iso H,Yamagishi K,et al.Alcohol consumption and risk of stroke and coronary heart disease among Japanese women:the Japan Public Health Center-based prospective study[J].Prev Med,2013,57(5):505-510. [22]Jood K,Jern C,Wilhelmsen L,et al.Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years[J].Stroke,2004,35(12):2764-2769. [23]Wannamethee SG,Shaper AG,Whincup PH,et al.Adiposity,adipokines,and risk of incident stroke in older menyears[J].Stroke,2013,44(1):3-8. [24]Huang YN,Gao S,Li SW,et al.Vascular lesions in Chinese patients with ischemic attacks.Neurology,1997,48(2):524-525. [25]Wong KS,Li H,Chan YL,et al.Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large artery occlusive disease[J].Stroke,2000,31:2641-2647. [26]Chimowitz MI,Lynn MJ,Derdeyn CP,et al.Stenting versus aggressive medical therapy for intracranial arterial stenosisyears[J].N Engl J Med,2011,365(11):993-1003. [27]N.Venketasubramanian,Seang-Mei Saw,et al.Hyperhomocyst(e)inemia and Risk of Ischemic Stroke Among Young Asian Adults[J].Stroke,2002,33:1956-1962. [28]Wald DS,Law M,Morris JK,Homocysteine and cardiovascular disease:evidence on causality from a meta-analysis[J].BMJ,2002,325(7374):1202. [29]Ramón Estruch,Emilio Ros,Jordi Salas-Salvadó,et al.Primary Prevention of Cardiovascular Disease with a Mediterranean Diet[J].N Engl J Med,2013,368(14):1279-1290. [30]Kulshreshtha A,Vaccarino V,Judd SE,et al.Life′s Simple 7 and risk of incident stroke:the reasons for geographic and racial differences in stroke study[J].Stroke,2013,44(7):1909.

相似文献/References:

[1]王兰勤.苯磺酸氨氯地平联合缬沙坦对长期透析伴高血压患者的治疗效果分[J].内科,2015,(01):19.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.08]
[2]李继志 陈奕 黄智武 徐家志 杨振宇.广西合浦县农村居民高血压患病及危险因素调查分析[J].内科,2015,(02):241.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.02.43]
 [J].Internal Medicine of China,2015,(01):241.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.02.43]
[3]关雪梅 寇翠兰.系统化健康教育对提高高血压患者自我管理疾病能力效果观察[J].内科,2014,(01):34.
 [J].Internal Medicine of China,2014,(01):34.
[4]韦联章.高血压患者伴发快速房性心律失常与左房室重塑关系的临床分析[J].内科,2014,(02):162.
 [J].Internal Medicine of China,2014,(01):162.
[5]詹秀娥 乔彩萍.赖诺普利与氨氯地平对老年性高血压患者左心室质量及舒张功能影响的Meta分析[J].内科,2014,(03):270.
 ZHAN Xiu-e,QIAO Cai-ping.The meta-analysis of the effects of lisinopril versus amlodipine on left ventricular mass and diastolic function in elderly patients with hypertension[J].Internal Medicine of China,2014,(01):270.
[6]黄惠容.高血压患者动态血压变异性与左心室肥厚的关系[J].内科,2014,(04):427.
 [J].Internal Medicine of China,2014,(01):427.
[7]庞群 奚翠云 莫薇.高血压健康管理方案对老年高血压患者治疗依从性的影响[J].内科,2014,(04):514.
 [J].Internal Medicine of China,2014,(01):514.
[8]黄伟英 徐富真 韩贵艳.综合护理干预对2型糖尿病合并高血压患者治疗效果的影响[J].内科,2014,(06):768.
 [J].Internal Medicine of China,2014,(01):768.
[9]吴隐雄 王小燕 张琴 赵毅兰 邓金龙 吴东峰 刘杰 廖钦晨 王舟 卢锋.培哚普利对老年轻中度高血压患者靶器官的保护作用[J].内科,2015,(05):597.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.01]
 WU Dong-feng,LIU Jie,LIAO Qin-chen,et al.Protective effect of perindopril on target organ in elderly patients with mild-to-moderate hypertension WU Yin-xiong1, WAN Xiao-yan2, ZHANG Qin3, ZHAO Yi-lan2, DENG Jin-long1,[J].Internal Medicine of China,2015,(01):597.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.01]
[10]孙静 冯彦林 赵巧红 陈萍玲 胡小怀 黄文清 邓君可 劳秋婵 彭宁.不同降压方案治疗原发性高血压临床效果比较分析[J].内科,2015,(05):646.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.17]
 [J].Internal Medicine of China,2015,(01):646.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.17]

更新日期/Last Update: 2015-09-29